GALT

Galectin Therapeutics Inc

GALT.US galectintherapeutics.com + Research + Basket
CIK 0001133416
Employees 9
Phone 678 620 3186
Fiscal year end December
IPO Sep 09, 2002
Address 4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071
2.96
-0.03 (-0.84%)
USD · NASDAQ
52-week range
2.03
7.13
Trading at 18% of the 52-week range
Market Cap
349.95M
P/E Ratio
0.00
Forward P/E
4.54
Book Value
-2.10
Div. Yield
N/A
% Institutions
15.77%
% Insiders
52.80%

1 Year

-47.0%

3 Year

+47.0%

10 Year

+405.9%
Description

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in a Phase 2 clinical study in MASH patients with advanced fibrosis and a second Phase 2b clinical trial in MASH patients with compensated cirrhosis and portal hypertension. It has a joint venture co-owned by SBH Sciences, Inc. to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Actions

Add an action for GALT.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Joel Lewis CPA President & CEO 1970
Mr. Jack W. Callicutt CPA CFO, Treasurer & Corporate Secretary 1967
Dr. Khurram Jamil M.D. Chief Medical Officer 1976
Mr. Robert Tritt J.D. General Counsel NA
Mr. Jim Wilkins Ph.D. Head of CMC & Pharmaceutical Development NA
Ms. Beth Knowles Executive Assistant & Officer Manager NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Feb 06, 2026 Kary Eldred N/A Purchase 300.00 $2.70 $810.00 SEC
Jan 06, 2026 Jack W Callicutt N/A Sale 20.35K $3.67 $74.70K SEC
Jan 06, 2026 Joel Lewis N/A Sale 37.70K $3.58 $134.96K SEC
Jan 06, 2026 Khurram Jamil N/A Sale 21.45K $3.65 $78.28K SEC
Jan 05, 2026 Jack W Callicutt N/A Sale 25.73K $3.90 $100.35K SEC
Jan 05, 2026 Joel Lewis N/A Sale 27.73K $3.91 $108.43K SEC
Jan 05, 2026 Khurram Jamil N/A Sale 25.50K $3.90 $99.45K SEC
Jan 02, 2026 Jack W Callicutt N/A Sale 13.91K $4.20 $58.44K SEC
Jan 02, 2026 Joel Lewis N/A Sale 18.57K $4.20 $78.00K SEC
Jan 02, 2026 Khurram Jamil N/A Sale 13.06K $4.20 $54.83K SEC
Dec 23, 2025 Kary Eldred N/A Purchase 700.00 $3.73 $2.61K SEC
Dec 17, 2025 Harold H Shlevin N/A Sale 24.50K $7.04 $172.47K SEC
Dec 17, 2025 Joel Lewis N/A Sale 7.83K $7.06 $55.27K SEC
Dec 17, 2025 Khurram Jamil N/A Sale 19.44K $7.04 $136.87K SEC
Dec 16, 2025 Fund L.P. 10X N/A Sale 30.68K $6.66 $204.34K SEC
Dec 09, 2025 Harold H Shlevin N/A Sale 16.79K $6.27 $105.27K SEC
Dec 08, 2025 Harold H Shlevin N/A Sale 159.00K $5.98 $950.82K SEC
Dec 03, 2025 Fund L.P. 10X N/A Sale 120.00K $5.73 $687.60K SEC
Dec 02, 2025 Fund L.P. 10X N/A Sale 30.00K $5.47 $164.10K SEC
Nov 13, 2025 Khurram Jamil N/A Sale 121.12K $5.47 $662.51K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 2.99M Jun 30, 2026 2.96% $0.00 273.90%
Vanguard Capital Management, LLC 2.17M Jun 30, 2026 2.15% $0.00 10.25%
Geode Capital Management, LLC 1.31M Jun 30, 2026 1.30% $0.00 113.52%
Advisor Group Holdings, Inc. 1.20M Jun 30, 2026 1.19% $0.01 7.22%
Marshall Wace Asset Management Ltd 831.01K Jun 30, 2026 0.82% $0.00 -31.88%
Sontag Advisory LLC 721.79K Jun 30, 2026 0.72% $0.02 0.00%
State Street Corp 567.78K Jun 30, 2026 0.56% $0.00 119.70%
Commonwealth Equity Services, LLC 407.11K Jun 30, 2026 0.40% $0.00 10.90%
Northern Trust Corp 386.55K Jun 30, 2026 0.38% $0.00 196.32%
Vanguard Fiduciary Trust Co 366.48K Jun 30, 2026 0.36% $0.00 20.46%
Vanguard Portfolio Management, LLC 327.77K Jun 30, 2026 0.33% $0.00 0.00%
Two Sigma Investments LLC 318.25K Jun 30, 2026 0.32% $0.00 -31.86%
LPL Financial Corp 285.38K Jun 30, 2026 0.28% $0.00 6.80%
CAMBRIDGE Invest RESEARCH ADVISORS, INC. 261.30K Jun 30, 2026 0.26% $0.00 103.11%
Sovran Advisors, LLC 258.00K Jun 30, 2026 0.26% $0.07 0.06%
Geneos Wealth Management Inc 240.43K Jun 30, 2026 0.24% $0.02 -0.21%
UBS Group AG 219.32K Jun 30, 2026 0.22% $0.00 22.02%
RETIREMENT GUYS FORMULA LLC 211.05K Jun 30, 2026 0.21% $0.37 12.83%
Citadel Advisors Llc 198.70K Jun 30, 2026 0.20% $0.00 -31.57%
Susquehanna International Group, LLP 177.20K Jun 30, 2026 0.18% $0.00 -68.11%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 1.52M 1.51% ▲ 0.00% Sep 30, 2026
2 iShares Russell 2000 ETF 1.16M 1.15% ▼ 0.41% Oct 29, 2026
3 Fidelity Small Cap Index 520.37K 0.52% ▲ 0.43% Jul 31, 2026
4 iShares Russell 2000 Growth ETF 314.63K 0.31% ▲ 0.25% Oct 29, 2026
5 Vanguard Russell 2000 ETF 279.87K 0.28% ▲ 1.59% Sep 30, 2026
6 Fidelity Extended Market Index 264.05K 0.26% ▼ 0.53% Aug 31, 2026
7 iShares Russell 2000 Value ETF 155.16K 0.15% ▼ 0.31% Oct 28, 2026
8 iShares Micro-Cap ETF 144.03K 0.14% ▲ 0.00% Oct 29, 2026
9 Schwab Small Cap Index 116.40K 0.12% ▲ 0.00% Sep 30, 2026
10 Fidelity Total Market Index 96.65K 0.10% ▲ 1.30% Aug 31, 2026

Financial Highlights

▼
Market Cap: $349.95M
PEG Ratio: $0.00
Book Value: $-2.10
Earnings/Share: $-0.43
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -64.18%
ROE (TTM): -3,727.95%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $463.53M
Trailing P/E: 0.00
Forward P/E: 4.54

Shares Statistics

Shares Outstanding: 100.85M
Shares Float: 47.85M
% Insiders: 52.80%
% Institutions: 15.77%
Shares Short: 9.13M
Shares Short (Prior Month): 9.21M
Short Ratio: 35.76
Short % Float: 11.86%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Gross Profit
subtotal
$0.00
SG&A
adjust
$-5.80M
R&D
adjust
$-14.29M
Operating Income
subtotal
$-20.09M
Other / Non-Operating Items
adjust
$-10.75M
Net Income
subtotal
$-30.84M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about GALT.US!